AG˹ٷ

STOCK TITAN

[144] Jazz Pharmaceuticals, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144
Rhea-AI Filing Summary

Form 144 notice reports a proposed sale of 3,731 shares of common stock of ETRADE FINANCIAL CORPORATION on NASDAQ with an aggregate market value of $417,872 and 60,658,809 shares outstanding. The securities were acquired on 08/07/2025 through restricted stock vesting from the issuer and the reported payment/nature is compensation. The proposed sale date is 08/08/2025. The filer reports no securities sold in the past three months and the filing is marked LIVE. The form includes the standard representation that the seller does not possess undisclosed material adverse information and references trading-plan/Rule 10b5-1 considerations.

Avviso Modulo 144 segnala una proposta di vendita di 3,731 azioni di capitale ordinario di ETRADE FINANCIAL CORPORATION su NASDAQ per un valore di mercato complessivo di $417,872 e con 60,658,809 azioni in circolazione. I titoli sono stati acquisiti il 08/07/2025 tramite il vesting di azioni vincolate dall’emittente e la natura del pagamento è dichiarata come compenso. La data prevista per la vendita è il 08/08/2025. Il dichiarante riferisce di non aver venduto titoli nei tre mesi precedenti e il deposito è contrassegnato come LIVE. Il modulo include la dichiarazione standard secondo cui il venditore non possiede informazioni negative rilevanti non divulgate e fa riferimento a considerazioni relative a piani di trading/regola 10b5-1.

Aviso del Formulario 144 informa una propuesta de venta de 3,731 acciones de acciones ordinarias de ETRADE FINANCIAL CORPORATION en NASDAQ por un valor de mercado agregado de $417,872 y con 60,658,809 acciones en circulación. Los valores fueron adquiridos el 08/07/2025 mediante vesting de acciones restringidas emitidas por la compañía y la naturaleza del pago se reporta como dzԲó. La fecha prevista de la venta es el 08/08/2025. El declarante informa no haber vendido valores en los últimos tres meses y la presentación está marcada como LIVE. El formulario incluye la declaración estándar de que el vendedor no posee información material adversa no divulgada y hace referencia a consideraciones sobre planes de negociación/Regla 10b5-1.

양식 144 통지NASDAQ에서 ETRADE FINANCIAL CORPORATION 보통� 3,731�� 매도 예정� � 시장 가� $417,872, 발행주식� 60,658,809�� 보고합니�. 해당 증권은 08/07/2025� 발행사로부� 제한주식� 베스�(vesting)으로 취득되었�, 보고� 지급의 성격은 보상입니�. 예정� 매도일은 08/08/2025입니�. 신고인은 과거 3개월� 매도� 증권� 없다� 보고했으�, 신고서 LIVE� 표시되어 있습니다. 해당 양식에 판매자가 비공개된 중대� 불리� 정보� 보유하고 있지 않다� 표준 진술� 포함되어 있으� 거래계획/Rule 10b5-1 관� 고려사항� 참조하고 있습니다.

Avis du formulaire 144 signale une proposition de vente de 3,731 actions ordinaires de ETRADE FINANCIAL CORPORATION sur le NASDAQ pour une valeur de marché agrégée de $417,872 et 60,658,809 actions en circulation. Les titres ont été acquis le 08/07/2025 par vesting d'actions restreintes émis par la société et la nature du paiement déclaré est la éܲéپDz. La date prévue de la vente est le 08/08/2025. Le déclarant signale aucune vente de titres au cours des trois derniers mois et le dépôt est marqué LIVE. Le formulaire comprend la déclaration standard selon laquelle le vendeur ne possède pas d'informations défavorables matérielles non divulguées et fait référence aux considérations relatives aux plans de négociation/règle 10b5-1.

Formular 144-Mitteilung meldet einen geplanten Verkauf von 3,731 Aktien Stammaktien der ETRADE FINANCIAL CORPORATION an der NASDAQ mit einem gesamtmarktwert von $417,872 und 60,658,809 ausstehenden Aktien. Die Wertpapiere wurden am 08/07/2025 durch Vesting von eingeschränkten Aktien vom Emittenten erworben und die gemeldete Zahlungsart/-natur ist ձüٳܲԲ. Das geplante Verkaufsdatum ist der 08/08/2025. Der Einreicher berichtet, in den letzten drei Monaten keine Wertpapiere verkauft zu haben, und die Einreichung ist als LIVE gekennzeichnet. Das Formular enthält die übliche Erklärung, dass der Verkäufer keine nicht offengelegten, wesentlichen nachteiligen Informationen besitzt, und verweist auf Überlegungen zu Handelsplänen/Regel 10b5-1.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: The proposed sale is immaterial to capitalization; value is $417,872 and represents ~0.0062% of outstanding shares.

The filing discloses a small, routine proposed sale of 3,731 shares valued at $417,872 against 60,658,809 shares outstanding, implying a negligible impact on market supply or company ownership. The shares were issued via restricted stock vesting the day before sale, and no prior sales in the past three months are reported. For investors, this is a compliance disclosure rather than a material corporate development.

TL;DR: Form 144 is a routine Rule 144 disclosure confirming proposed sale and the seller's representation about lack of undisclosed material information.

The document follows Rule 144 mechanics: it identifies the class, broker, proposed sale date, acquisition method (restricted stock vesting), and contains the sellers certification about material nonpublic information. It also notes the option for trading-plan/Rule 10b5-1 adoption language. There are no red flags such as large block sales, prior three-month sales, or unusual consideration terms disclosed.

Avviso Modulo 144 segnala una proposta di vendita di 3,731 azioni di capitale ordinario di ETRADE FINANCIAL CORPORATION su NASDAQ per un valore di mercato complessivo di $417,872 e con 60,658,809 azioni in circolazione. I titoli sono stati acquisiti il 08/07/2025 tramite il vesting di azioni vincolate dall’emittente e la natura del pagamento è dichiarata come compenso. La data prevista per la vendita è il 08/08/2025. Il dichiarante riferisce di non aver venduto titoli nei tre mesi precedenti e il deposito è contrassegnato come LIVE. Il modulo include la dichiarazione standard secondo cui il venditore non possiede informazioni negative rilevanti non divulgate e fa riferimento a considerazioni relative a piani di trading/regola 10b5-1.

Aviso del Formulario 144 informa una propuesta de venta de 3,731 acciones de acciones ordinarias de ETRADE FINANCIAL CORPORATION en NASDAQ por un valor de mercado agregado de $417,872 y con 60,658,809 acciones en circulación. Los valores fueron adquiridos el 08/07/2025 mediante vesting de acciones restringidas emitidas por la compañía y la naturaleza del pago se reporta como dzԲó. La fecha prevista de la venta es el 08/08/2025. El declarante informa no haber vendido valores en los últimos tres meses y la presentación está marcada como LIVE. El formulario incluye la declaración estándar de que el vendedor no posee información material adversa no divulgada y hace referencia a consideraciones sobre planes de negociación/Regla 10b5-1.

양식 144 통지NASDAQ에서 ETRADE FINANCIAL CORPORATION 보통� 3,731�� 매도 예정� � 시장 가� $417,872, 발행주식� 60,658,809�� 보고합니�. 해당 증권은 08/07/2025� 발행사로부� 제한주식� 베스�(vesting)으로 취득되었�, 보고� 지급의 성격은 보상입니�. 예정� 매도일은 08/08/2025입니�. 신고인은 과거 3개월� 매도� 증권� 없다� 보고했으�, 신고서 LIVE� 표시되어 있습니다. 해당 양식에 판매자가 비공개된 중대� 불리� 정보� 보유하고 있지 않다� 표준 진술� 포함되어 있으� 거래계획/Rule 10b5-1 관� 고려사항� 참조하고 있습니다.

Avis du formulaire 144 signale une proposition de vente de 3,731 actions ordinaires de ETRADE FINANCIAL CORPORATION sur le NASDAQ pour une valeur de marché agrégée de $417,872 et 60,658,809 actions en circulation. Les titres ont été acquis le 08/07/2025 par vesting d'actions restreintes émis par la société et la nature du paiement déclaré est la éܲéپDz. La date prévue de la vente est le 08/08/2025. Le déclarant signale aucune vente de titres au cours des trois derniers mois et le dépôt est marqué LIVE. Le formulaire comprend la déclaration standard selon laquelle le vendeur ne possède pas d'informations défavorables matérielles non divulguées et fait référence aux considérations relatives aux plans de négociation/règle 10b5-1.

Formular 144-Mitteilung meldet einen geplanten Verkauf von 3,731 Aktien Stammaktien der ETRADE FINANCIAL CORPORATION an der NASDAQ mit einem gesamtmarktwert von $417,872 und 60,658,809 ausstehenden Aktien. Die Wertpapiere wurden am 08/07/2025 durch Vesting von eingeschränkten Aktien vom Emittenten erworben und die gemeldete Zahlungsart/-natur ist ձüٳܲԲ. Das geplante Verkaufsdatum ist der 08/08/2025. Der Einreicher berichtet, in den letzten drei Monaten keine Wertpapiere verkauft zu haben, und die Einreichung ist als LIVE gekennzeichnet. Das Formular enthält die übliche Erklärung, dass der Verkäufer keine nicht offengelegten, wesentlichen nachteiligen Informationen besitzt, und verweist auf Überlegungen zu Handelsplänen/Regel 10b5-1.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What securities are being offered for sale in this Form 144?

3,731 shares of common stock of ETRADE FINANCIAL CORPORATION are proposed for sale.

When is the proposed sale date and on which exchange will it occur?

Proposed sale date: 08/08/2025; Exchange: NASDAQ.

How were the shares acquired and when were they paid for?

Acquisition: Restricted stock vesting from the issuer on 08/07/2025; Nature of payment: Compensation on 08/07/2025.

What is the aggregate market value and how many shares are outstanding?

Aggregate market value: $417,872; Shares outstanding: 60,658,809.

Were any securities of the issuer sold by this person in the past three months?

No. The filer reports Nothing to Report for securities sold in the past three months.
Jazz Pharmaceuticals Plc

NASDAQ:JAZZ

JAZZ Rankings

JAZZ Latest News

JAZZ Latest SEC Filings

JAZZ Stock Data

6.41B
58.66M
3.04%
101.99%
9.46%
Biotechnology
Pharmaceutical Preparations
Ireland
DUBLIN